Prostate-Specific Antigen (PSA) Screening for Prostate Cancer Revisiting the Evidence

被引：19
|
作者：
Carter, H. Ballentine [1 ,2 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 319卷 / 18期
关键词：
SERVICES TASK-FORCE; QUALITY-OF-LIFE; METASTATIC-DISEASE; MORTALITY; TRIAL; RISK; MEN; ASSOCIATION; DIAGNOSIS; OUTCOMES;
D O I：
10.1001/jama.2018.4914
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1866 / 1868
页数：3
相关论文
共 50 条
  • [41] Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion
    Basch, Ethan
    Oliver, Thomas K.
    Vickers, Andrew
    Thompson, Ian
    Kantoff, Philip
    Parnes, Howard
    Loblaw, D. Andrew
    Roth, Bruce
    Williams, James
    Nam, Robert K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (24) : 3020 - 3025
  • [42] Prostate-specific antigen screening, why have the guidelines changed?
    Sountoulides, Petros
    Moutzouris, Georgios
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (11) : 1277 - 1281
  • [43] Prostate-specific antigen testing across the spectrum of prostate cancer
    Haythorn, Mark R.
    Ablin, Richard J.
    BIOMARKERS IN MEDICINE, 2011, 5 (04) : 515 - 526
  • [44] The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test
    McCormick, Mallory E.
    Haile, Zelalem T.
    JOURNAL OF CANCER EDUCATION, 2023, 38 (04) : 1313 - 1321
  • [45] Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement
    Sundaresan, Vinaik M.
    Smani, Shayan
    Rajwa, Pawel
    Renzulli, Joseph
    Sprenkle, Preston C.
    Kim, Isaac Y.
    Leapman, Michael S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (01) : 41 - 48
  • [46] Prostate-specific antigen screening impacts on biochemical recurrence in patients with clinically localized prostate cancer
    Hashimoto, Takeshi
    Ohori, Makoto
    Shimodaira, Kenji
    Kaburaki, Naoto
    Hirasawa, Yosuke
    Satake, Naoya
    Gondo, Tatsuo
    Nakagami, Yoshihiro
    Namiki, Kazunori
    Ohno, Yoshio
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (06) : 561 - 567
  • [47] Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts
    Rove, Kyle O.
    Crawford, E. David
    WORLD JOURNAL OF UROLOGY, 2012, 30 (02) : 137 - 142
  • [48] On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer
    Bangma, Chris H.
    van Schaik, Ron H.
    Blijenberg, Bert G.
    Roobol, Monique J.
    Lilja, Hans
    Stenman, Ulf-Hakan
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (17) : 3109 - 3119
  • [49] Prostate-specific antigen-based screening for prostate cancer: Evidence, controversies and future perspectives
    Ito, Kazuto
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (05) : 458 - 464
  • [50] Recommendations on Use of Prostate-Specific Antigen for Prostate Cancer Screening Reply
    Miller, David C.
    Hollenbeck, Brent K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (13): : 1373 - 1374
12345